Open AccessRisk factors for nephrotoxicity onset associated with polymyxin B therapy
Author(s) -
Yanina Dubrovskaya,
Nishant Prasad,
Yuman Lee,
Diana Esaian,
Deborah A. Figueroa,
Vincent H. Tam
Publication year - 2015
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkv014
Subject(s) - nephrotoxicity , polymyxin b , medicine , polymyxin , antibiotic therapy , intensive care medicine , antibiotics , microbiology and biotechnology , toxicity , biology
Polymyxin B is an active agent against many MDR Gram-negative bacteria, but nephrotoxicity is a major hindrance to its widespread use. To guide its optimal use, we determined the risk factors for nephrotoxicity onset associated with polymyxin B.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom